MTAR Technologies (NSE: MTARTECH) dropped about 10.6% to Rs 6,355 on roughly twice its average volume - its third sharp fall this month after declines of ~7% on June 1 and ~8% on June 8.
The trigger: Crusoe pauses Project Jade
Market reports today said US data-centre developer Crusoe has paused work on Project Jade, a planned 1.8-gigawatt campus in Cheyenne, Wyoming, where Bloom Energy was contracted as the fuel-cell supplier.
Why does a Wyoming construction pause hit a Hyderabad precision-engineering stock this hard? Customer concentration. MTAR is a long-standing supplier of hot-box assemblies for Bloom Energy's solid-oxide fuel cells, and Bloom is estimated to account for roughly 55–65% of MTAR's consolidated revenue. Anything that clouds Bloom's order pipeline transmits almost directly into MTAR's growth expectations.
What the numbers show
The business itself has been delivering: from company filings, FY26 revenue rose to Rs 876 crore from Rs 676 crore (+30%) and net profit to Rs 94 crore from Rs 53 crore (+78%). The March quarter was its best ever - revenue Rs 322.5 crore, net profit Rs 44.3 crore.
The tension is in the price, not the results. Even after today's fall the stock is up ~304% over one year, and trades at a trailing P/E around 208. At that kind of multiple, the market is paying today for many years of expected growth - so news that threatens the growth pipeline (rather than current earnings) produces outsized reactions.
What the tape says
Delivery was ~26% of traded quantity versus an 18% average for this counter - higher-than-usual delivery on a falling day, which suggests genuine position reduction rather than purely intraday selling.
Promoter holding is 30.4%. The stock now sits about 25% below its 52-week high of Rs 8,449 while still far above its 52-week low of Rs 1,390.
--- This article is for education and information only. It is not investment advice, and Stocks Sena does not recommend buying or selling any security. Numbers are from exchange filings and our data platform; always verify with official sources before acting.